Revenue, 2025

USD 1.24 Billion

Forecast, 2035

USD 2.8 Billion

CAGR, 2026-2035

8.48%

Report Coverage

Global

Antimicrobial Urinary Catheters Market Trends for 2026

The global antimicrobial urinary catheters market size was estimated at USD 1.24 billion in 2025 and is predicted to increase from USD 1.35 billion in 2026 to approximately USD 2.8 billion by 2035, expanding at a CAGR of 8.48% from 2026 to 2035.

The market is growing steadily due to increased focus on reducing catheter-associated infections, technological advancements in coatings, and rising healthcare expenditure, with strong demand from hospitals and aging populations driving future expansion.

Key Takeaways

• Antimicrobial urinary catheters sector pushed the market to USD 1.35 billion by 2026.
• Long-term projections show USD 2.8 billion valuation by 2035.
• Growth is expected at a steady CAGR of 8.48% in between 2026 to 2035.
• North America dominated the antimicrobial urinary catheters market in 2025.
• Asia Pacific is expected to grow at the fastest CAGR in the market during the forecast period.
• By product, the intermittent catheters segment held a dominant position in the market by 46% in 2025.
• By product, the external catheters segment is expected to grow at the fastest CAGR in the market during the forecast period.
• By material, the silicon-based segment registered dominance in the market by 44% in 2025.
• By material, the PVC/vinyl segment is expected to grow at a notable CAGR in the market during the forecast period.
• By coating, the hydrophilic coatings segment led the market by 38% in 2025.
• By coating, the silver-based coatings segment is expected to grow at a notable CAGR in the market during the forecast period.
• By catheterization, the short-term segment dominated the market by 63% in 2025.
• By catheterization, the long-term segment is expected to grow at a significant CAGR in the market during the forecast period.
• By end use, the hospitals (ICU/acute care) segment held the largest antimicrobial urinary catheters market by 48% share in 2025.
• By end use, the long-term care (nursing homes) segment is expected to grow at the fastest CAGR in the market during the forecast period.

Rising Demand for Infection-Preventive Catheters

Antimicrobial urinary catheters are medical tubes coated or impregnated with antimicrobial agents to prevent bacterial growth and reduce the risk of catheter-associated urinary tract infections (CAUTIs) during drainage. The antimicrobial urinary catheters market is growing due to increasing cases of catheter-associated urinary tract infections (CAUTIs), rising hospitalizations, and the aging population. Advancements in catheter coatings, greater awareness of infection prevention, and higher healthcare spending are driving adoption in hospitals and clinics. These factors collectively boost demand for safer, infection-resistant urinary care solutions worldwide.

How Can AI Affect the Antimicrobial Urinary Catheters Market?

Artificial intelligence can influence the antimicrobial urinary catheter market by improving infection prediction and patient monitoring in hospitals. AI-based analytics can identify patients at high risk of catheter-associated infections, helping clinicians choose advanced antimicrobial catheters. It can also support smarter hospital inventory management and guide research in developing more effective antimicrobial coatings, improving patient outcomes, and encouraging adoption of advanced catheter technologies.

Trend and Future Outlook of the Antimicrobial Urinary Catheters Market

• Innovation in Antimicrobial Materials: Companies are focusing on developing improved antimicrobial coatings and materials that can better prevent bacterial growth on catheters. Continuous innovation in silver-based, antibiotic-infused, and other protective technologies is expected to enhance product performance and support long-term market growth.
• Increasing Focus on Infection Prevention: Hospitals and healthcare providers are prioritizing strategies that reduce hospital-acquired infections. As catheter-associated urinary tract infections remain a major concern, healthcare facilities are increasingly adopting antimicrobial catheters to improve patient safety and treatment outcomes.
• Rising Use in Home and Long-Term Care Settings: The shift toward home healthcare and long-term patient management is creating new opportunities for antimicrobial urinary catheters. Patients requiring prolonged catheterization prefer safer and more infection-resistant devices, encouraging manufacturers to design user-friendly and durable catheter solutions.

Key Indicators and Highlights

Segmental Insights

By Product Insights

Why Did the Intermittent Catheters Segment Dominate in the Antimicrobial Urinary Catheters Market in 2025?

The intermittent catheters segment dominated the market by 46% in 2025 due to their lower risk of infection compared with indwelling catheters. They are widely recommended for short-term bladder management and self-catheterization, particularly among patients with neurological disorders. Their convenience, reduced complications, and growing use in home healthcare settings further supported strong adoption across hospitals and outpatient care.

External Catheters

The external catheters segment is expected to grow at the fastest CAGR due to their non-invasive design and lower risk of urinary tract infections compared to indwelling catheters. Increasing preference for comfortable and easy-to-use devices, especially among male patients and elderly individuals, is driving adoption. Additionally, rising use in home care settings and improved product design are further supporting the rapid growth of the segment.

By Material Insights

What Made the Silicon-Based Segment Dominant in the Antimicrobial Urinary Catheters Market in 2025?

The silicon-based segment dominated the market by 44% in 2025 due to its high biocompatibility, flexibility, and lower risk of irritation during long-term catheterization. Silicon materials also allow better integration of antimicrobial coatings, helping reduce bacterial colonization. Their durability, patient comfort, and sustainability for extended medical use encouraged hospitals and healthcare providers to prefer silicon-based catheters over other materials.

PVC/vinyl

The PVC/vinyl segment is expected to grow at a notable CAGR due to its affordability and widespread availability compared to silicon-based alternatives. These materials are commonly used for short-term catheterization in hospitals because they are easy to manufacture and cost-efficient. Growing healthcare demand in emerging markets and increasing hospital procedures are further supporting the rising adoption of PVC/vinyl antimicrobial urinary catheters.

By Coating Insights

How Does the Hydrophilic Coatings Segment Dominate the Antimicrobial Urinary Catheters Market in 2025?

The hydrophilic coatings segment dominated the antimicrobial urinary catheter market by 38% in 2025 due to its ability to create a smooth, lubricated surface when activated by water. This reduces friction during catheter insertion and removal, improving patient comfort and minimizing urethral irritation. In addition, hydrophilic coatings help limit bacterial adherence, supporting infection control and encouraging widespread use in hospitals and long-term care settings.

Silver-based Coatings

The silver-based coatings segment is expected to grow at a notable CAGR due to its strong and long-lasting antimicrobial properties. Silver ions effectively inhibit bacterial growth on catheter surfaces, reducing the risk of catheter-associated urinary tract infections. Increasing focus on infection prevention, along with rising hospital adoption of advanced antimicrobial technologies, is expected to accelerate demand for silver-based antimicrobial urinary products during the forecast period.

By Catheterization Insights

How Did the Short-Term Segment Dominate the Antimicrobial Urinary Catheters Market in 2025?

The short-term segment dominated the market by 63% in 2025 due to its widespread use during surgeries, post-operative care, and temporary urinary retention treatment. Hospitals frequently prefer short-term catheters to minimize infection risks and complications associated with prolonged catheter use. Increasing surgical procedures and hospital admissions further contributed to the strong demand for short-term antimicrobial catheter solutions.

long-term

The long-term segment is expected to grow at a significant CAGR due to the rising prevalence of chronic conditions such as urinary retention, spinal cord injuries, and neurological disorders. Many patients require continuous bladder management for extended periods, increasing demand for durable antimicrobial catheters. Additionally, the expansion of home healthcare and long-term care facilities is further supporting the rapid growth of this segment.

By End Use Insights

Why the Hospitals (ICU/acute care) Segment Dominated the Antimicrobial Urinary Catheters Market?

The hospitals (ICU/acute care) segment dominated the antimicrobial urinary catheter market by 48% due to the high number of hospitalized patients requiring continuous monitoring and urinary changes. Critically ill patients, surgical cases, and emergency admissions often need catheterization, increasing demand for infection-prevention devices. Hospitals also prioritize advanced antimicrobial solutions to reduce hospital-acquired infections, which further strengthens the dominance of this segment.

Long-term care (nursing homes)

The long-term care (nursing homes) segment is expected to grow at the fastest CAGR due to the increasing elderly population requiring continuous medical support and urinary management. Many residents in nursing homes need prolonged catheterization because of mobility limitations and chronic illness. This growing demand for safe and infection-resistant catheter solutions is encouraging greater adoption of antimicrobial urinary catheters in long-term care facilities.

Regional Insights

Advanced Healthcare Infrastructure Driving North America Leadership

North America dominated the antimicrobial urinary catheters market in 2025 due to its well-established healthcare infrastructure, high awareness of infection prevention, and strong adoption of advanced medical devices. The region also benefits from higher healthcare spending, a large number of surgical procedures, and strict hospital infection control guidelines. In addition, the presence of leading medical device manufacturers further strengthened market growth across the region.

Strong Healthcare Investment Supporting U.S. Market Leadership

The U.S. antimicrobial urinary catheters market led in 2025 due to high healthcare spending, advanced hospital infrastructure, and a strong focus on preventing hospital-acquired infections. A large number of surgical procedures and critically ill patients requiring catheterization also increased demand. In addition, the presence of major medical device companies and continuous product innovation further supported the country’s dominant position in the market.

Expanding Healthcare Access Driving Asia Pacific Market Growth

Asia Pacific is anticipated to grow at the fastest CAGR due to improving healthcare infrastructure, rising medical expenditures, and increasing awareness about infection prevention. The region’s large and aging population, along with growing hospital admissions and surgical procedures, is boosting demand for antimicrobial urinary catheters. Moreover, expanding healthcare facilities and stronger government support for healthcare facilities and stronger government support for healthcare development are further accelerating the antimicrobial urinary catheters market growth.

Rapid Healthcare Development Supporting India Market Expansion

India is expected to grow at the fastest CAGR in the antimicrobial urinary catheters market due to improving healthcare infrastructure, rising healthcare expenditure, and increasing awareness of infection control. A large patient population, a growing number of surgical procedures, and expanding hospital networks are boosting demand. Additionally, government healthcare initiatives and increasing access to advanced medical devices are further accelerating market growth across the country.

Supply Chain Analysis

R&D

• Research and development in antimicrobial urinary catheters focuses on lowering catheter-associated urinary tract infections (CAUTIs), responsible for nearly 70–80% of hospital-acquired UTIs. Current innovations emphasize stronger and longer-lasting antimicrobial coatings for extended use. Companies are increasingly using materials such as silver, antibiotics, and hydrogels to improve infection control.
• Key players: Becton, Dickinson and Company, Medline Industries, ConvaTec Group plc, Well Lead Medical, and Silq Technologies.

Clinical Trials

• Clinical trials for antimicrobial urinary catheters mainly evaluate their ability to lower catheter-associated urinary tract infections (CAUTIs). These studies compare antimicrobial-coated catheters, such as silver-alloy, nitrofurazone, or antibiotic-treated devices, with standard catheters. Many trials report reduced bacterial growth, but results on lowering symptomatic infections remain inconsistent, particularly for long-term use. 
• Key players: Becton, Dickinson and Company, Teleflex Incorporated, ConvaTec Group plc, Medline Industries, and Coloplast A/S.

Patient Support and Services

• Patient support and service programs for antimicrobial urinary catheters focus on ensuring safe use and effective infection prevention. These services include proper catheter insertion, regular maintenance, patient and caregiver education, and timely removal to lower the risk of catheter-associated urinary tract infections (CAUTIs). Such support helps improve patient safety and treatment outcomes.
• Key players: Becton, Dickinson and Company, Coloplast A/S, ConvaTec Group plc, Teleflex Incorporated, and Medline Industries.

Top Vendors in the Antimicrobial Urinary Catheters Market & Their Offerings

SWOT Analysis

Strengths

• Antimicrobial coatings help limit bacterial growth on catheter surfaces, which can lower the risk of catheter-associated urinary tract infections and improve patient safety.
• Increasing focus on infection prevention in hospitals encourages the use of advanced catheter technologies.
• Continuous product innovation in materials and coatings improves durability, performance, and patient comfort.

Weaknesses

• Antimicrobial urinary catheters are usually more expensive than conventional catheters, which may limit adoption in cost-sensitive healthcare systems.
• Clinical studies sometimes show inconsistent results in reducing symptomatic infections.

Opportunities

• The growing elderly population and rising prevalence of chronic diseases increase the need for long-term urinary management solutions.
• Expansion of home healthcare and long-term care facilities supports wider use of infection-control catheters.
• Improving healthcare infrastructure in emerging economies creates new market growth opportunities.

Threats

• Strict regulatory approval processes for medical devices can slow the introduction of new catheter technologies.
• Hospitals may prefer lower-cost standard catheters when budgets are limited. 

What are the Recent Developments in the Antimicrobial Urinary Catheters Market?

• In May 2024, Laborie Medical Technologies reported encouraging two- and five-year clinical study outcomes for its Optilume BPH Catheter System, a minimally invasive treatment designed for benign prostatic hyperplasia. The results, shared at the American Urological Association Annual Meeting in San Antonio, Texas, showed lasting improvements in urinary flow and symptom relief, with a low need for retreatment and no negative effect on sexual function. These findings highlight the company’s ongoing focus on advancing urology treatments through research and innovation.
• In April 2024, Medline Industries formed an exclusive distribution partnership with Consure Medical to supply the QiVi External Urinary Management System. The agreement is intended to strengthen Medline’s urinary care product range and support healthcare providers with improved solutions for managing urinary incontinence in clinical settings.

Segments Covered in the Report

By Product

• Intermittent Catheters
• Foley/Indwelling Catheters
• External Catheters

By Material

• Latex-Based
• Silicone-Based
• PVC/Vinyl

By Coating

• Silver-Based Coatings
• Antibiotic-Impregnated
• Hydrophilic Coatings
• Others

By Catheterization

• Long-Term
• Short-Term

By End Use

• Hospitals (ICU/Acute Care)
• Long-Term Care (Nursing Homes)
• Home Care Setting
• Ambulatory Surgical Centers

By Region

• North America
  • U.S.
  • Canada 
  • Mexico 
  • Rest of North America
• Latin America
  • Brazil
  • Argentina
  • Rest of Latin America
• Europe 
  • Western Europe 
    • Germany 
    • Italy
    • France
    • Netherlands
    • Spain
    • Portugal 
    • Belgium
    • Ireland
    • UK 
    • Iceland 
    • Switzerland
    • Poland
    • Rest of Western Europe
  • Eastern Europe 
    • Austria
    • Russia & Belarus 
    • Türkiye
    • Albania 
    • Rest of Eastern Europe 
• Asia Pacific
  • China 
  • Taiwan
  • India 
  • Japan 
  • Australia and New Zealand
  • ASEAN Countries (Singapore, Malaysia)
  • South Korea 
  • Rest of APAC 
• MEA 
  • GCC Countries
    • Saudi Arabia 
    • United Arab Emirates (UAE)
    • Qatar 
    • Kuwait 
    • Oman 
    • Bahrain 
  • South Africa
  • Egypt 
  • Rest of MEA